3,3',5,5'-tetramethylbenzidine has been researched along with EHS Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Filimonov, A; Filimonova, M; Ivanov, S; Kaprin, A; Koryakin, S; Makarchuk, V; Saburov, V; Saburova, A; Sevankaeva, L; Shegay, P; Shevchenko, L; Surinova, V; Yakovleva, N; Yuzhakov, V | 1 |
1 other study(ies) available for 3,3',5,5'-tetramethylbenzidine and EHS Tumor
Article | Year |
---|---|
The Ability of the Nitric Oxide Synthases Inhibitor T1023 to Selectively Protect the Non-Malignant Tissues.
Topics: Animals; Carcinoma, Ehrlich Tumor; Female; Gamma Rays; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase; Radiation Protection; Radiation-Protective Agents; Radiodermatitis; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental; Thiourea | 2021 |